Condition
Myocardial Fibrosis clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Myocardial Fibrosis clinical trials that are recruiting, at sites in 7 countries (most in United States (2), Singapore (1), Portugal (1)). By phase: Phase 2 (1), Phase 1 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 7Countries
Newest Myocardial Fibrosis clinical trials
All recruiting trials (8)
-
Myocardial Perfusion and Tissue Characterization with Photon-Counting CT in TAVI Patients
This study tests whether photon-counting CT can measure heart blood flow and tissue properties as well as MRI in patients planning a TAVI procedure.
-
Gallium-68 FAPI PET/CT to find cardiac fibrosis in heart failure
This test will use a Gallium-68 FAPI PET/CT scan to see if it can detect active heart muscle fibrosis in adults with heart failure.
-
Assessing heart tissue damage in patients with heart aneurysms after a heart attack
This study is testing how heart tissue damage looks in patients with heart aneurysms after a heart attack using special imaging to see if it helps understand their condition better.
-
Triple-drug therapy (ARNI + SGLT2 inhibitor + MRA) for advanced HFpEF
This study will test whether giving an ARNI together with an SGLT2 inhibitor and an MRA helps people with advanced HFpEF stay healthier over 52 weeks compared with individualized medical therapy.
-
High-relaxivity Elucirem contrast for cardiac MRI to detect myocardial scar
This test will see if a half dose of Elucirem (gadopiclenol) can detect heart muscle scar as well as a double dose of Dotarem in adults who previously had cardiac MRI.
-
Gene therapy for heart issues in Friedreich's ataxia
This study is testing a new gene therapy for heart problems in people with Friedreich's ataxia to see if it is safe and helps improve their heart function.
-
Improving cardiovascular risk stratification with T1 mapping in the general population
This project will test whether CMR T1/T2 mapping can detect early heart inflammation or fibrosis and help predict cardiovascular risk in adults without known heart disease, including people after COVID-19 infection or vaccination.
-
Understanding heart muscle response to high blood pressure
This study looks at how high blood pressure affects the heart muscle in people with hypertension to see if certain heart changes can help improve treatment strategies.
Related topics
Quick answers
How many Myocardial Fibrosis clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in United States (2 trials), Singapore (1 trial), Portugal (1 trial), Germany (1 trial), Russia (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.